
Education and Training
- M.D., Duke University, 1999
Haines, Krista L., Lauren M. Woldanski, Tiffany Zens, Cory Vatsaas, Amy Alger, Kelli Brooks, George Kasotakis, and Suresh Agarwal. “The Impact of Race and Socioeconomic Status on Treatment and Outcomes of Blunt Splenic Injury.” J Surg Res 240 (August 2019): 60–69. https://doi.org/10.1016/j.jss.2019.02.040.
Sigurdsson, Martin I., Benjamin Brockbank, John C. Haney, Jon Andrews, David B. MacLeod, Steven N. Vaslef, Kelli R. Brooks, Erin L. Manning, and Alina Nicoara. “Abdominal Gunshot Causing Ventricular Septal Injury Without Perforation into the Pericardium.” J Cardiothorac Vasc Anesth 33, no. 3 (March 2019): 772–75. https://doi.org/10.1053/j.jvca.2018.02.038.
Haines, Krista L., Benjamin P. Nguyen, Cory Vatsaas, Amy Alger, Kelli Brooks, and Suresh K. Agarwal. “Socioeconomic Status Affects Outcomes After Severity-Stratified Traumatic Brain Injury.” J Surg Res 235 (March 2019): 131–40. https://doi.org/10.1016/j.jss.2018.09.072.
Kram, Bridgette L., Shawn J. Kram, and Kelli R. Brooks. “Implications of atypical antipsychotic prescribing in the intensive care unit.” J Crit Care 30, no. 4 (August 2015): 814–18. https://doi.org/10.1016/j.jcrc.2015.03.030.
Brooks, Kelli R., John E. Scarborough, Steven N. Vaslef, and Mark L. Shapiro. “No need to wait: an analysis of the timing of cholecystectomy during admission for acute cholecystitis using the American College of Surgeons National Surgical Quality Improvement Program database.” J Trauma Acute Care Surg 74, no. 1 (January 2013): 167–73. https://doi.org/10.1097/TA.0b013e3182788b71.
Bennett, Kyla M., Steven N. Vaslef, Mark L. Shapiro, Kelli R. Brooks, and John E. Scarborough. “Does intent matter? The medical and societal burden of self-inflicted injury.” J Trauma 67, no. 4 (October 2009): 841–47. https://doi.org/10.1097/TA.0b013e3181b24cd3.
D’Amico, Thomas A., Kelli R. Brooks, Mary-Beth Moore Joshi, Debbi Conlon, James Herndon, Rebecca P. Petersen, and David H. Harpole. “Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.” Ann Thorac Surg 81, no. 6 (June 2006): 1982–87. https://doi.org/10.1016/j.athoracsur.2006.01.042.
Harpole, D., M. B. M. Joshi, R. P. Petersen, C. C. Miller, D. Conlon, K. R. Brooks, and T. A. D’Amico. “Monitoring tumor markers in serial sera predicts disease failure in lung cancer patients following surgery.” In Journal of Clinical Oncology, 23:630S-630S. AMER SOC CLINICAL ONCOLOGY, 2005.
Brooks, Kelli R., Kathleen To, Mary-Beth Moore Joshi, Debbi H. Conlon, James E. Herndon, Thomas A. D’Amico, and David H. Harpole. “Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection.” Ann Thorac Surg 76, no. 1 (July 2003): 187–93. https://doi.org/10.1016/s0003-4975(03)00131-0.
Lau, Christine L., Mary-Beth H. Moore, Kelly R. Brooks, Thomas A. D’Amico, and David H. Harpole. “Molecular staging of lung and esophageal cancer.” Surg Clin North Am 82, no. 3 (June 2002): 497–523. https://doi.org/10.1016/s0039-6109(02)00024-5.